Citation: | CHEN Jiajia, BEI Yuncheng, ZHANG Dongmei, SHEN Pingping. Combination of artemether with etoposide inhibits cell proliferation and invasion in small cell lung cancer cell line H446[J]. Journal of China Pharmaceutical University, 2017, 48(2): 201-207. DOI: 10.11665/j.issn.1000-5048.20170211 |
[1] |
Byers LA,Rudin CM.Small cell lung cancer:where do we go from here[J]?Cancer,2015,121(5):664-672.
|
[2] |
Asai N,Ohkuni Y,Kaneko N,et al.Relapsed small cell lung cancer:treatment options and latest developments[J].Ther Adv Med Oncol,2014,6(2):69-82.
|
[3] |
Chaturvedi D,Goswami A,Saikia PP,et al.Artemisinin and its derivatives:a novel class of anti-malarial and anti-cancer agents[J].Chem Soc Rev,2010,39(2):435-454.
|
[4] |
Chen T,Li M,Zhang R,et al.Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy[J].J Cell Mol Med,2009,13(7):1358-1370.
|
[5] |
Gong Y,Gallis BM,Goodlett DR,et al.Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines[J].Anticancer Res,2013,33(1):123-132.
|
[6] |
Lai HC,Singh NP,Sasaki T.Development of artemisinin compounds for cancer treatment[J].Invest New Drugs,2013,31(1):230-46.
|
[7] |
Lu JJ, Chen SM, Zhang XW, et al. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells[J].Invest New Drugs,2011,29(6):1276-1283.
|
[8] |
Das AK.Anticancer effect of antimalarial artemisinin compounds[J].Ann Med Health Sci Res,2015,5(2):93-102.
|
[9] |
Guo T,Li HY,Yin XZ,et al. Mechanism of cyclodextrin inclusion of artemisinins in vacuum[J].J China Pharm Univ(中国药科大学学报),2010,41(6):513-519.
|
[10] |
Simos D,Sajjady G,Sergi M,et al.Third-line chemotherapy in small-cell lung cancer:an international analysis[J].Clin Lung Cancer,2014,15(2):110-118.
|
[11] |
Ho WE,Peh HY,Chan TK,et al.Artemisinins:pharmacological actions beyond anti-malarial[J].Pharmacol Ther,2014,142(1):126-139.
|
[1] | TANG qian, CHEN Roufen, SHEN Zheyuan, CHI Xinglong, CHE Jinxin, DONG Xiaowu. Research progress of artificial intelligence-based small molecule generation models in drug discovery[J]. Journal of China Pharmaceutical University, 2024, 55(3): 295-305. DOI: 10.11665/j.issn.1000-5048.2024031501 |
[2] | Gao Zhonghao. 新型药物递送系统技术在药物研发中的应用和展望[J]. Journal of China Pharmaceutical University, 2023, 54(1): 1-4. DOI: 10.11665/j.issn.1000-5048.2023030303 |
[3] | FU Mingyu, ZHU Yiyang, WU Chunyong, HOU Fengzhen, GUAN Yuan. Prediction of plasma protein binding rate based on machine learning[J]. Journal of China Pharmaceutical University, 2021, 52(6): 699-706. DOI: 10.11665/j.issn.1000-5048.20210607 |
[4] | MEI Jiahao, HONG Ze, WANG Chen. Advances of drugs in targeting cGAS-STING signaling pathway[J]. Journal of China Pharmaceutical University, 2020, 51(3): 249-259. DOI: 10.11665/j.issn.1000-5048.20200301 |
[5] | ZHANG Jing. Analysis on research and development of global cardiovascular drugs in the past 6 years[J]. Journal of China Pharmaceutical University, 2018, 49(6): 760-765. DOI: 10.11665/j.issn.1000-5048.20180619 |
[6] | WANG Chen, ZHANG Zhewen, LI Yingchun, ZHANG Xiquan, ZHAO Wei. Advances of the effects of antibody heterogeneity on the function and metabolism of monoclonal antibody drugs[J]. Journal of China Pharmaceutical University, 2017, 48(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20170518 |
[7] | Yeast for New Drug Research[J]. Journal of China Pharmaceutical University, 2004, (6): 109-113. |
[8] | Gene Knockout Model and New Drug Target Discovery[J]. Journal of China Pharmaceutical University, 2004, (1): 3-8. |
[9] | Application of Genechip Technology in Drug Discovery and Development[J]. Journal of China Pharmaceutical University, 2001, (2): 1-6. |
[10] | Advances and Prospects of Drug Discovery and Development Zhang Yihua, Peng Sixun, Hua Weiyi[J]. Journal of China Pharmaceutical University, 1999, (2): 75-80. |